Apotheca Biosciences announce the intent to purchase Nano Creaciones S.A. P.I. de D.V. Research LLC (Nano). Nano currently holds several patents and patents pending for the treatment of certain medical conditions, and Apotheca Biosciences is thrilled to be able to leverage their existing technology for the development of next generation CBD-based OTC formulations. Nano is on the cutting-edge of nanotechnology through their development of a cotton fiber gauze with silver nitrate nanoparticles that allow the users to discard any risk of wound infection while accelerating their tissue regeneration process. Currently, Nano is in the process of testing and fielding such medications for regulatory approval, studies, marketing, production and sales. Nano’s product has been tested in all aspects from the development and active duration of the nanoparticles to the packaging of the gauze and its density to allow its proper sterilization without damaging the product. Nano has fully developed gauze, band-aids and sprays, while developing a line of the same products to include using CBD as a palliative. The Nano Gauze is made from pure silver nanoparticles, which are carefully dispersed in cotton fibers that are subjected to a meticulous sterilization process with the most advanced technology for contact with wounds and human tissues without compromising the action of the silver nanostructures. Apotheca Biosciences believes that using Nano’s products to deliver CBD as a palliative will bring the utmost quality and precise dosing to the consumer market.